Quick Answer
BioNTech SE reported Gross Profit of $91.23 million for the year ending 2019.
- BioNTech SE showed a decrease of -19.9% in Gross Profit from 2018 to 2019.
- This data is from BioNTech SE's annual report (Form 10-K), filed with the SEC on March 31, 2020.
- XBRL data for this metric is available from 2017 to 2019 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2017 to 2019), BioNTech SE's Gross Profit has grown by 74.5%.
- Historical annual values: Fiscal year 2019: $91.23 million | Fiscal year 2018: $113.89 million | Fiscal year 2017: $52.28 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: